Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone

Madison Casten1, Jamie L Miller1, Stephen B Neely1

  • 1University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.

Insights

Opioid conversion calculators (OCCs) show significant variability when converting fentanyl to hydromorphone in critically ill children. Clinicians should exercise caution due to these inconsistent opioid conversion results.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Pain Management

Background:

  • Opioid conversion calculators (OCCs) are essential tools for medication management.
  • Accurate opioid conversion is critical for effective pain management and patient safety, especially in vulnerable pediatric populations.

Purpose of the Study:

  • To quantify and describe the variability in opioid conversion calculator (OCC) results.
  • To assess the range of hydromorphone infusion rates derived from various OCCs in critically ill children transitioning from fentanyl.

Main Methods:

  • A descriptive, retrospective study analyzing data from 28 critically ill children (<18 years).
  • Seventeen different OCCs were utilized to calculate hydromorphone infusion rates from fentanyl.
  • Calculated rates were compared against a defined hydromorphone stabilization rate from prior research.

Main Results:

  • A wide median hydromorphone rate range (0.06 to 0.12 mg/kg/h) was observed across the 17 OCCs.
  • Certain OCC groups (3 and 6) frequently overestimated the required hydromorphone dose, while others (4 and 5) underestimated it.
  • Significant discrepancies between calculated and stabilization hydromorphone rates were noted, highlighting substantial variability.

Conclusions:

  • Considerable variability exists among different opioid conversion calculators for fentanyl to hydromorphone conversion in pediatric critical care.
  • The findings underscore the need for caution and critical evaluation when using OCCs in this patient population.
  • Further research may be warranted to standardize OCCs or develop more reliable conversion methods for pediatric patients.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
97
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
82
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
216